Leukemia & Lymphoma, Volume 57, Issue 5 (2016)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 57, Issue 5 (2016)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Volume 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentaries

Article Commentary
Chronic lymphocytic leukemia and proteomics: protein profiles and links with disease progression still need validation
Clive S. Zent
Pages: 985-986
Published online: 04 Jan 2016
CitationforChronic lymphocytic leukemia and proteomics: protein profiles and links with disease progression still need validation | Full Text | References | PDF (227.6 KB) | Supplemental
  • 148 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Dose-reduced fludarabine, cyclophosphamide and rituximab (FCR) in older patients with chronic lymphocytic leukemia: does one size fit all?
Paula Cramer, Petra Langerbeins, Kirsten Fischer, Barbara Eichhorst, Michael Hallek & Valentin Goede
Pages: 987-990
Published online: 20 Apr 2016
First Page PreviewforDose-reduced fludarabine, cyclophosphamide and rituximab (FCR) in older patients with chronic lymphocytic leukemia: does one size fit all? | Full Text | References | PDF (359.4 KB) | Supplemental
  • 307 Views
  • 2 CrossRef citations
  • 0Altmetric
Article Commentary
Lymphoplasmacytic lymphoma: What we need to know
Rajshekar Chakraborty & Morie A. Gertz
Pages: 991-992
Published online: 13 Oct 2015
CitationforLymphoplasmacytic lymphoma: What we need to know | Full Text | References | PDF (229.5 KB) | Supplemental
  • 280 Views
  • 3 CrossRef citations
  • 0Altmetric
Article Commentary
Bendamustine and stem-cell mobilization: not so bad!
Jay Patrick Lopez & Tsiporah B Shore
Pages: 993-994
Published online: 02 Mar 2016
CitationforBendamustine and stem-cell mobilization: not so bad! | Full Text | References | PDF (227 KB) | Supplemental
  • 200 Views
  • 0 CrossRef citations
  • 0Altmetric

Reviews

Immune checkpoint pathways: perspectives on myeloid malignancies
Gabriel A. Rivera, Iman Saramipoor Behbahan & Peter L. Greenberg
Pages: 995-1001
Published online: 25 Feb 2016
AbstractforImmune checkpoint pathways: perspectives on myeloid malignancies | Full Text | References | PDF (840 KB) | Supplemental
  • 832 Views
  • 4 CrossRef citations
  • 0Altmetric
Considering baseline factors and early response rates to optimize therapy for chronic myeloid leukemia in chronic phase
Luke P. Akard & Dale Bixby
Pages: 1002-1014
Published online: 04 Jan 2016
AbstractforConsidering baseline factors and early response rates to optimize therapy for chronic myeloid leukemia in chronic phase | Full Text | References | PDF (946.5 KB) | Supplemental
  • 641 Views
  • 3 CrossRef citations
  • 0Altmetric
Malignant hematopoietic cell lines: in vitro models for double-hit B-cell lymphomas
Hans G. Drexler, Sonja Eberth, Stefan Nagel & Roderick A. F. MacLeod
Pages: 1015-1020
Published online: 04 Jan 2016
AbstractforMalignant hematopoietic cell lines: in vitro models for double-hit B-cell lymphomas | Full Text | References | PDF (1 MB) | Supplemental
  • 1711 Views
  • 22 CrossRef citations
  • 0Altmetric

Emerging Drug Profile

Blinatumomab: a CD19/CD3 bispecific T cell engager (BiTE) with unique anti-tumor efficacy
Maria-Elisabeth Goebeler & Ralf Bargou
Pages: 1021-1032
Published online: 06 Apr 2016
AbstractforBlinatumomab: a CD19/CD3 bispecific T cell engager (BiTE) with unique anti-tumor efficacy | Full Text | References | PDF (2 MB) | Supplemental
  • 4245 Views
  • 90 CrossRef citations
  • 0Altmetric

Original Articles: Clinical

Article
Protein profiles distinguish stable and progressive chronic lymphocytic leukemia
Pauline Y. Huang, Swetlana Mactier, Natalie Armacki, O. Giles Best, Larissa Belov, Kimberley L. Kaufman, Dana Pascovici, Stephen P. Mulligan & Richard I. Christopherson
Pages: 1033-1043
Published online: 16 Nov 2015
AbstractforProtein profiles distinguish stable and progressive chronic lymphocytic leukemia | Full Text | References | PDF (2.7 MB) | Supplemental
  • 459 Views
  • 8 CrossRef citations
  • 0Altmetric
Dose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy
Thomas E. Lew, Chan Y. Cheah, Dennis A. Carney, H. Miles Prince, Max Wolf, Ali Bazargan, E. Henry Januszewicz, Robin Filshie, David Westerman, John F. Seymour & Constantine S. Tam
Pages: 1044-1053
Published online: 20 Nov 2015
AbstractforDose-reduced fludarabine, cyclophosphamide and rituximab is well tolerated in older patients with chronic lymphocytic leukemia and has preserved therapeutic efficacy | Full Text | References | PDF (758 KB) | Supplemental
  • 429 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Chronic lymphocytic leukemia and myeloproliferative neoplasms concurrently diagnosed: clinical and biological characteristics
Gabriele Todisco, Taghi Manshouri, Srdan Verstovsek, Lucia Masarova, Sherry A. Pierce, Michael J. Keating & Zeev Estrov
Pages: 1054-1059
Published online: 19 Oct 2015
AbstractforChronic lymphocytic leukemia and myeloproliferative neoplasms concurrently diagnosed: clinical and biological characteristics | Full Text | References | PDF (539.4 KB) | Supplemental
  • 491 Views
  • 13 CrossRef citations
  • 0Altmetric
Total body-surface area as a new prognostic variable in mycosis fungoides and Sézary syndrome
Silvana Novelli, Pilar García-Muret, Anna Mozos, Jorge Sierra & Javier Briones
Pages: 1060-1066
Published online: 11 Jan 2016
AbstractforTotal body-surface area as a new prognostic variable in mycosis fungoides and Sézary syndrome | Full Text | References | PDF (1.1 MB) | Supplemental
  • 197 Views
  • 8 CrossRef citations
  • 0Altmetric
Prognostic relevance of DHAP dose-density in relapsed Hodgkin lymphoma: an analysis of the German Hodgkin-Study Group
Stephanie Sasse, Magdalena Alram, Horst Müller, Lenka Smardová, Bernd Metzner, Hartmut Doehner, Thomas Fischer, Dietger W. Niederwieser, Norbert Schmitz, Kerstin Schäfer-Eckart, John M. M. Raemaekers, Oliver Schmalz, Bastian V. Tresckow, Andreas Engert & Peter Borchmann
Pages: 1067-1073
Published online: 23 Dec 2015
AbstractforPrognostic relevance of DHAP dose-density in relapsed Hodgkin lymphoma: an analysis of the German Hodgkin-Study Group | Full Text | References | PDF (766.4 KB) | Supplemental
  • 547 Views
  • 8 CrossRef citations
  • 0Altmetric
Impact of delays in definitive treatment on overall survival: a National Cancer Database study of patients with Hodgkin lymphoma
Rahul R. Parikh, Michael. L. Grossbard, Louis. B. Harrison & Joachim Yahalom
Pages: 1074-1082
Published online: 15 Oct 2015
AbstractforImpact of delays in definitive treatment on overall survival: a National Cancer Database study of patients with Hodgkin lymphoma | Full Text | References | PDF (949.1 KB) | Supplemental
  • 269 Views
  • 4 CrossRef citations
  • 0Altmetric
Lymph nodes can accurately be measured on PET-CT for lymphoma staging/restaging without a concomitant contrast enhanced CT scan
William L. Simpson Jr, Karen M. Lee, Ninoska Sosa, Nancy Cooper, Eileen Scigliano, Joshua D. Brody, John T. Doucette & Lale Kostakoglu
Pages: 1083-1093
Published online: 16 Nov 2015
AbstractforLymph nodes can accurately be measured on PET-CT for lymphoma staging/restaging without a concomitant contrast enhanced CT scan | Full Text | References | PDF (1.1 MB) | Supplemental
  • 185 Views
  • 3 CrossRef citations
  • 0Altmetric
Impact of rituximab maintenance and maintenance schedule on prognosis in first-line treatment of follicular lymphoma. Retrospective analysis from Czech Lymphoma Study Group (CLSG) database
Andrea Janikova, Zbynek Bortlicek, Vit Campr, Natasa Kopalova, Katerina Benesova, Jitka Hamouzova, David Belada, Vit Prochazka, Robert Pytlik, Samuel Vokurka, Jan Pirnos, Juraj Duras, Heidi Mocikova, Jiri Mayer & Marek Trneny
Pages: 1094-1103
Published online: 12 Oct 2015
AbstractforImpact of rituximab maintenance and maintenance schedule on prognosis in first-line treatment of follicular lymphoma. Retrospective analysis from Czech Lymphoma Study Group (CLSG) database | Full Text | References | PDF (1.1 MB) | Supplemental
  • 415 Views
  • 7 CrossRef citations
  • 0Altmetric
Clinicopathologic features and outcomes of lymphoplasmacytic lymphoma patients with monoclonal IgG or IgA paraprotein expression
Xin Cao, L. Jeffrey Medeiros, Yi Xia, Xiaoxiao Wang, Sheeba K. Thomas, Sanam Loghavi, Xin Li, Jatin J. Shah, Steven A. Gustafson, Donna M. Weber, Roberto N. Miranda, Zijun Y. Xu-Monette, Robert Z. Orlowski & Ken H. Young
Pages: 1104-1113
Published online: 23 Dec 2015
AbstractforClinicopathologic features and outcomes of lymphoplasmacytic lymphoma patients with monoclonal IgG or IgA paraprotein expression | Full Text | References | PDF (2.1 MB) | Supplemental
  • 1124 Views
  • 33 CrossRef citations
  • 0Altmetric
Article
Bone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imaging
Manisha Bhutani, Baris Turkbey, Esther Tan, Neha Korde, Mary Kwok, Elisabet E. Manasanch, Nishant Tageja, Sham Mailankody, Mark Roschewski, Marcia Mulquin, Ashley Carpenter, Elizabeth Lamping, Alex R. Minter, Brendan M. Weiss, Esther Mena, Liza Lindenberg, Katherine R. Calvo, Irina Maric, Saad Z. Usmani, Peter L. Choyke, Karen Kurdziel & Ola Landgren
Pages: 1114-1121
Published online: 07 Apr 2016
AbstractforBone marrow abnormalities and early bone lesions in multiple myeloma and its precursor disease: a prospective study using functional and morphologic imaging | Full Text | References | PDF (1.3 MB) | Supplemental
  • 570 Views
  • 17 CrossRef citations
  • 0Altmetric
Stem cell mobilization chemotherapy with gemcitabine is effective and safe in myeloma patients with bortezomib-induced neurotoxicity
Beatrice U. Mueller, Sandra Keller, Katja Seipel, Behrouz Mansouri Taleghani, Daniel Rauch, Daniel Betticher, Thomas Egger & Thomas Pabst
Pages: 1122-1129
Published online: 12 Oct 2015
AbstractforStem cell mobilization chemotherapy with gemcitabine is effective and safe in myeloma patients with bortezomib-induced neurotoxicity | Full Text | References | PDF (625.8 KB) | Supplemental
  • 219 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Cost-effectiveness of rituximab in addition to fludarabine and cyclophosphamide (R-FC) for the first-line treatment of chronic lymphocytic leukemia
Dirk Müller, Kirsten Fischer, Peter Kaiser, Barbara Eichhorst, Ronald Walshe, Marcel Reiser, Lenka Kellermann, Lisa Borsi, Daniele Civello, Alexander Mensch, Jasmin Bahlo, Michael Hallek, Stephanie Stock & Günter Fingerle-Rowson
Pages: 1130-1139
Published online: 20 Nov 2015
AbstractforCost-effectiveness of rituximab in addition to fludarabine and cyclophosphamide (R-FC) for the first-line treatment of chronic lymphocytic leukemia | Full Text | References | PDF (887.3 KB) | Supplemental
  • 524 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
Association between body mass index at diagnosis and pediatric leukemia mortality and relapse: a systematic review and meta-analysis
Ernest K. Amankwah, Ashleigh M. Saenz, Gregory A. Hale & Patrick A. Brown
Pages: 1140-1148
Published online: 09 Oct 2015
AbstractforAssociation between body mass index at diagnosis and pediatric leukemia mortality and relapse: a systematic review and meta-analysis | Full Text | References | PDF (759.1 KB) | Supplemental
  • 683 Views
  • 38 CrossRef citations
  • 0Altmetric
Article
Does bendamustine impact the mobilization of peripheral blood stem cells? A multicenter retrospective study of 23 cases
Anne-Claire Gac, Nabih Azar, Etienne Daguindau, Guillaume Cartron, Luc M. Fornecker, Emmanuel Gyan, Florence Broussais-Guillaumot, Reda Garidi, Bachra Choufi, Sylvain P. Chantepie, Marie-Christine Béné, Romain Guiéze, Fontanet Bijou, Remy Gressin, Sandy Amorim & Gandhi Damaj
Pages: 1149-1153
Published online: 15 Feb 2016
AbstractforDoes bendamustine impact the mobilization of peripheral blood stem cells? A multicenter retrospective study of 23 cases | Full Text | References | PDF (538.5 KB) | Supplemental
  • 323 Views
  • 5 CrossRef citations
  • 0Altmetric

Original Articles: Research

Article
Silibinin suppresses NPM-ALK, potently induces apoptosis and enhances chemosensitivity in ALK-positive anaplastic large cell lymphoma
Ommoleila Molavi, Nasser Samadi, Chengsheng Wu, Afsaneh Lavasanifar & Raymond Lai
Pages: 1154-1162
Published online: 28 Sep 2015
AbstractforSilibinin suppresses NPM-ALK, potently induces apoptosis and enhances chemosensitivity in ALK-positive anaplastic large cell lymphoma | Full Text | References | PDF (1.7 MB) | Supplemental
  • 352 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
Genetic alterations in glucocorticoid signaling pathway components are associated with adverse prognosis in children with relapsed ETV6/RUNX1-positive acute lymphoblastic leukemia
Reinhard Grausenburger, Stephan Bastelberger, Cornelia Eckert, Maximilian Kauer, Martin Stanulla, Christian Frech, Eva Bauer, Dagmar Stoiber, Arend von Stackelberg, Andishe Attarbaschi, Oskar A. Haas & Renate Panzer-Grümayer
Pages: 1163-1173
Published online: 09 Oct 2015
AbstractforGenetic alterations in glucocorticoid signaling pathway components are associated with adverse prognosis in children with relapsed ETV6/RUNX1-positive acute lymphoblastic leukemia | Full Text | References | PDF (1.1 MB) | Supplemental
  • 630 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
The application of CD73 in minimal residual disease monitoring using flow cytometry in B-cell acute lymphoblastic leukemia
Wei Wang, Li Gao, Yan Li, Zhen-Ling Li, Ming Gong, Fan-Zhou Huang, Yan-Rong Chen, Chun-Xia Zhang, Ya-Yue Gao & Yi-Gai Ma
Pages: 1174-1181
Published online: 05 Oct 2015
AbstractforThe application of CD73 in minimal residual disease monitoring using flow cytometry in B-cell acute lymphoblastic leukemia | Full Text | References | PDF (1.5 MB) | Supplemental
  • 637 Views
  • 13 CrossRef citations
  • 0Altmetric
Article
Expression, prognostic significance and mutational analysis of protein tyrosine phosphatase SHP-1 in chronic myeloid leukemia
Vasiliki Papadopoulou, Elina Kontandreopoulou, Panayiotis Panayiotidis, Maria Roumelioti, Maria Angelopoulou, Lydia Kyriazopoulou, Panagiotis T. Diamantopoulos, George Vaiopoulos, Eleni Variami, Ioannis Kotsianidis & Nora Athina Viniou
Pages: 1182-1188
Published online: 23 Dec 2015
AbstractforExpression, prognostic significance and mutational analysis of protein tyrosine phosphatase SHP-1 in chronic myeloid leukemia | Full Text | References | PDF (818.6 KB) | Supplemental
  • 139 Views
  • 3 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter
Adequacy of peripheral blood stem cell mobilization in patients with relapsed B-cell non-Hodgkin lymphoma treated with bendamustine
Andrew Iliff, Clint Divine, Francisco Diaz, Omar Aljitawi, Sunil Abhayankar, Joseph McGuirk & Siddhartha Ganguly
Pages: 1189-1190
Published online: 12 Oct 2015
CitationforAdequacy of peripheral blood stem cell mobilization in patients with relapsed B-cell non-Hodgkin lymphoma treated with bendamustine | Full Text | References | PDF (220 KB) | Supplemental
  • 214 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Outcomes with R-CEOP for R-CHOP-ineligible patients with diffuse large B-cell lymphoma are highly dependent on cell of origin defined by Hans criteria
Armin Rashidi, Eunhye Oak, Kenneth R. Carson, Nina D. Wagner-Johnston, Friederike Kreisel & Nancy L. Bartlett
Pages: 1191-1193
Published online: 20 Oct 2015
First Page PreviewforOutcomes with R-CEOP for R-CHOP-ineligible patients with diffuse large B-cell lymphoma are highly dependent on cell of origin defined by Hans criteria | Full Text | References | PDF (509.2 KB) | Supplemental
  • 1995 Views
  • 18 CrossRef citations
  • 0Altmetric
Letter
Remission of an extensively pre-treated relapsing/refractory ALK-positive anaplastic large cell lymphoma following metronomic therapy
Shunzong Yuan, Jianhua Yu, Brad Haverkos & Hang Su
Pages: 1194-1196
Published online: 06 Jan 2016
First Page PreviewforRemission of an extensively pre-treated relapsing/refractory ALK-positive anaplastic large cell lymphoma following metronomic therapy | Full Text | References | PDF (359.9 KB) | Supplemental
  • 186 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
A population-based analysis of second malignancies among patients with myeloproliferative neoplasms in the SEER database
Andrew M. Brunner, Gabriela Hobbs, Marla M. Jalbut, Donna S. Neuberg & Amir T. Fathi
Pages: 1197-1200
Published online: 21 Aug 2015
First Page PreviewforA population-based analysis of second malignancies among patients with myeloproliferative neoplasms in the SEER database | Full Text | References | PDF (416.9 KB) | Supplemental
  • 387 Views
  • 5 CrossRef citations
  • 0Altmetric
Letter
Apoptosis- and cell cycle-related genes methylation profile in myeloproliferative neoplasms
Raquel Tognon, Natália S. Nunes, Luciana Ambrosio, Elizabeth Xisto Souto, Leila Perobelli, Belinda Pinto Simões, Mariana Cristina Lima Souza, Maria de Lourdes Chauffaille & Fabíola Attié de Castro
Pages: 1201-1204
Published online: 05 Oct 2015
First Page PreviewforApoptosis- and cell cycle-related genes methylation profile in myeloproliferative neoplasms | Full Text | References | PDF (470.7 KB) | Supplemental
  • 160 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Does outcome of second salvage therapy in relapsed or refractory acute myeloid leukemia depend on intensity of either first or second salvage therapy?
Daisuke Araki, Megan Othus, Roland B. Walter, Pamela S. Becker, Vicky Sandhu & Elihu H. Estey
Pages: 1205-1207
Published online: 23 Dec 2015
First Page PreviewforDoes outcome of second salvage therapy in relapsed or refractory acute myeloid leukemia depend on intensity of either first or second salvage therapy? | Full Text | References | PDF (418.7 KB) | Supplemental
  • 223 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Bendamustine reactivates latent Epstein-Barr virus
Samantha G. Fernandez & JJ L. Miranda
Pages: 1208-1210
Published online: 15 Sep 2015
First Page PreviewforBendamustine reactivates latent Epstein-Barr virus | Full Text | References | PDF (385.5 KB) | Supplemental
  • 1494 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Letter
Comparison of International Prognostic Index and NCCN-IPI in 324 patients with de novo diffuse large B-cell lymphoma: a multi-center retrospective analysis
Erman Öztürk, Murat Özbalak, Selin Berk, Işıl Erdoğan, Emin Avşar, Anıl Dolgun, Mustafa Çetiner, Nil Molinas Mandel, Fevzi Fırat Yalnız, Tuğrul Elverdi, Ayşe Salihoğlu, Ahmet Emre Eşkazan, Muhlis Cem Ar, Şeniz Öngören, Zafer Başlar, Yıldız Aydın, Teoman Soysal & Burhan Ferhanoğlu
Pages: 1211-1214
Published online: 12 Oct 2015
First Page PreviewforComparison of International Prognostic Index and NCCN-IPI in 324 patients with de novo diffuse large B-cell lymphoma: a multi-center retrospective analysis | Full Text | References | PDF (651 KB) | Supplemental
  • 329 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Modulation of bone marrow microenvironment following ruxolitinib therapy in myelofibrosis
Giovanni Caocci, Antonio Maccioni, Francesca Murgia, Alessandra Perra, Monica Usai, Michela Piga, Roberto Mascia & Giorgio La Nasa
Pages: 1215-1218
Published online: 05 Oct 2015
First Page PreviewforModulation of bone marrow microenvironment following ruxolitinib therapy in myelofibrosis | Full Text | References | PDF (665.8 KB) | Supplemental
  • 1496 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Letter
Complexity of NOTCH1 juxtamembrane insertion mutations in T-cell acute lymphoblastic leukemia
Sara Colomer-Lahiguera & Sabine Strehl
Pages: 1219-1222
Published online: 09 Oct 2015
First Page PreviewforComplexity of NOTCH1 juxtamembrane insertion mutations in T-cell acute lymphoblastic leukemia | Full Text | References | PDF (2 MB) | Supplemental
  • 169 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Copper deficiency mimicking myelodysplastic syndrome
Kirsty Rady, David Westerman, Piers Blombery, Paul Turner & John Seymour
Pages: 1223-1226
Published online: 23 Dec 2015
First Page PreviewforCopper deficiency mimicking myelodysplastic syndrome | Full Text | References | PDF (706.4 KB) | Supplemental
  • 316 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Autoimmune thyroid dysfunction after allogeneic hematopoietic stem cell transplant
Yusuke Isshiki, Keiko Ono, Katsuhiro Shono, Masahiro Onoda & Akira Yokota
Pages: 1227-1229
Published online: 08 Mar 2016
First Page PreviewforAutoimmune thyroid dysfunction after allogeneic hematopoietic stem cell transplant | Full Text | References | PDF (294.4 KB) | Supplemental
  • 195 Views
  • 11 CrossRef citations
  • 0Altmetric
Letter
Decreased normal NK-cells is a characteristic of T-cell large granular lymphocytic leukemia and is strongly associated with cytopenia
Min Shi, Jadee L. Neff, Dragan Jevremovic & William G. Morice
Pages: 1230-1233
Published online: 21 Dec 2015
First Page PreviewforDecreased normal NK-cells is a characteristic of T-cell large granular lymphocytic leukemia and is strongly associated with cytopenia | Full Text | References | PDF (832 KB) | Supplemental
  • 237 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Association of CFHR1 homozygous deletion with acute myelogenous leukemia in the European population
Maddalena Fratelli, Marco Bolis, Mami Kurosaki, Martina Dori, Valeria Guarnaccia, Orietta Spinelli, Marta Alberti, Elisabetta Valoti, Silvana Pileggi, Marina Noris, Giuseppe Remuzzi, Alessandro Rambaldi, Mineko Terao & Enrico Garattini
Pages: 1234-1237
Published online: 02 Mar 2016
First Page PreviewforAssociation of CFHR1 homozygous deletion with acute myelogenous leukemia in the European population | Full Text | References | PDF (984.8 KB) | Supplemental
  • 188 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Long-term follow-up of previously treated and treatment-naïve patients who received tositumomab and I-131 tositumomab
Thierry J. Horner, Vanessa C. Williams, Patricia Giampietro, Philip A. Witman & Thomas S. Lin
Pages: 1238-1240
Published online: 23 Dec 2015
First Page PreviewforLong-term follow-up of previously treated and treatment-naïve patients who received tositumomab and I-131 tositumomab | Full Text | References | PDF (287.2 KB) | Supplemental
  • 107 Views
  • 0 CrossRef citations
  • 0Altmetric

Statements of Retraction

Retraction
Hu Jie, He Donghua, Xue Xingkui, Gao Liang, Wu Wenjun, Han Xiaoyan, Cai Zhen, Homoharringtonine-induced apoptosis of MDS cell line MUTZ-1 cells is mediated by the endoplasmic reticulum stress pathway, May 2007;48(5):964–977. http://dx.doi.org/10.1080/10428190701216360
Page: 1241
Published online: 08 Mar 2016
CitationforHu Jie, He Donghua, Xue Xingkui, Gao Liang, Wu Wenjun, Han Xiaoyan, Cai Zhen, Homoharringtonine-induced apoptosis of MDS cell line MUTZ-1 cells is mediated by the endoplasmic reticulum stress pathway, May 2007;48(5):964–977. http://dx.doi.org/10.1080/10428190701216360 | Full Text | PDF (74.3 KB)
  • 1583 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Retraction
Jun Ji, Dr Li Zhang, Yuan-Yuan Wu, Xiao-Yu Zhu, Su-Qing Lv, Xi-Zuo Sun, Induction of apoptosis by d-limonene is mediated by a caspase-dependent mitochondrial death pathway in human leukemia cells. December 2006;47(12):2617–2624. http://dx.doi.org/10.1080/00268970600909205
Page: 1242
Published online: 08 Mar 2016
CitationforJun Ji, Dr Li Zhang, Yuan-Yuan Wu, Xiao-Yu Zhu, Su-Qing Lv, Xi-Zuo Sun, Induction of apoptosis by d-limonene is mediated by a caspase-dependent mitochondrial death pathway in human leukemia cells. December 2006;47(12):2617–2624. http://dx.doi.org/10.1080/00268970600909205 | Full Text | PDF (74.2 KB)
  • 1528 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Retraction
Peihua Luo, Meili Lin, Meihua Lin, Yiyu Chen, Bo Yang, Qiaojun He, Function of retinoid acid receptor a and p21 in all-trans-retinoic acid-induced acute T-lymphoblastic leukemia apoptosis. July 2009;50(7):1183–1189. http://dx/doi.org/10.1080/10428190902934936
Page: 1243
Published online: 07 Mar 2016
CitationforPeihua Luo, Meili Lin, Meihua Lin, Yiyu Chen, Bo Yang, Qiaojun He, Function of retinoid acid receptor a and p21 in all-trans-retinoic acid-induced acute T-lymphoblastic leukemia apoptosis. July 2009;50(7):1183–1189. http://dx/doi.org/10.1080/10428190902934936 | Full Text | PDF (74.1 KB)
  • 929 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Retraction
Wei Zhang, Bao-an Chen, Jun-fei Jin, You-ji He, and Yi-qi Niu, Involvement of c-Jun N-terminal kinase in reversal of multidrug resistance of human leukemia cells in hypoxia by 5-bromotetrandrine. November 2013;54(11):2506–2516. http://dx.doi.org/10.3109/10428194.2013.776681
Page: 1244
Published online: 04 Mar 2016
CitationforWei Zhang, Bao-an Chen, Jun-fei Jin, You-ji He, and Yi-qi Niu, Involvement of c-Jun N-terminal kinase in reversal of multidrug resistance of human leukemia cells in hypoxia by 5-bromotetrandrine. November 2013;54(11):2506–2516. http://dx.doi.org/10.3109/10428194.2013.776681 | Full Text | PDF (74.1 KB)
  • 1309 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Corrigenda

Correction
Corrigendum
Page: 1245
Published online: 11 Apr 2016
CitationforCorrigendum | Full Text | PDF (181.4 KB)
  • 324 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Correction
Corrigendum
Page: 1246
Published online: 11 Apr 2016
CitationforCorrigendum | Full Text | PDF (300.1 KB)
  • 329 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Correction
Huang PY, mactier S, armacki N, et al. Protein profiles distinguish stable and progressive chronic lymphocytic leukemia. Leuk lymphoma 2016;57:1033–1043. http://dx.doi.org/10.3109/10428194.2015.1094692
Page: I
Published online: 16 Dec 2015
CitationforHuang PY, mactier S, armacki N, et al. Protein profiles distinguish stable and progressive chronic lymphocytic leukemia. Leuk lymphoma 2016;57:1033–1043. http://dx.doi.org/10.3109/10428194.2015.1094692 | Full Text | PDF (75.4 KB)
  • 531 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles